Glaukos Corp Stock Buy Hold or Sell Recommendation
| GKOS Stock | USD 144.00 3.17 2.25% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Glaukos Corp is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Glaukos Corp given historical horizon and risk tolerance towards Glaukos Corp. When Macroaxis issues a 'buy' or 'sell' recommendation for Glaukos Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Glaukos Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Glaukos Stock please use our How to Invest in Glaukos Corp guide. Note, we conduct extensive research on individual companies such as Glaukos and provide practical buy, sell, or hold advice based on investors' constraints. Glaukos Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Glaukos |
Execute Glaukos Corp Buy or Sell Advice
The Glaukos recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Glaukos Corp. Macroaxis does not own or have any residual interests in Glaukos Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Glaukos Corp's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Glaukos Corp Trading Alerts and Improvement Suggestions
| The company reported the previous year's revenue of 314.71 M. Net Loss for the year was (134.66 M) with profit before overhead, payroll, taxes, and interest of 213.88 M. | |
| Glaukos Corp currently holds about 391.19 M in cash with (57.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22. | |
| Glaukos Corp has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Glaukos Co. Shares Sold by Segall Bryant Hamill LLC |
Glaukos Corp Returns Distribution Density
The distribution of Glaukos Corp's historical returns is an attempt to chart the uncertainty of Glaukos Corp's future price movements. The chart of the probability distribution of Glaukos Corp daily returns describes the distribution of returns around its average expected value. We use Glaukos Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Glaukos Corp returns is essential to provide solid investment advice for Glaukos Corp.
| Mean Return | 0.18 | Value At Risk | -2.86 | Potential Upside | 3.30 | Standard Deviation | 2.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Glaukos Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Glaukos Stock Institutional Investors
The Glaukos Corp's institutional investors refer to entities that pool money to purchase Glaukos Corp's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Primecap Management Company | 2024-09-30 | 1.2 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.2 M | Geode Capital Management, Llc | 2024-06-30 | 1.1 M | Artisan Partners Limited Partnership | 2024-06-30 | 1 M | Driehaus Capital Management Llc | 2024-06-30 | 803.6 K | Gilder Gagnon Howe & Co Llc | 2024-09-30 | 658.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 641.8 K | Point72 Asset Management, L.p. | 2024-06-30 | 570 K | Loomis, Sayles & Company Lp | 2024-06-30 | 554.2 K | Blackrock Inc | 2024-06-30 | 8 M | Fmr Inc | 2024-09-30 | 6.6 M |
Glaukos Corp Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 4.1M | 2.0M | (7.7M) | (15.5M) | (4.8M) | (4.6M) | |
| Change In Cash | 33.2M | 34.4M | 4.0M | 16.5M | (27.3M) | (25.9M) | |
| Free Cash Flow | (5.1M) | (29.9M) | (23.1M) | (63.3M) | (78.0M) | (74.1M) | |
| Depreciation | 9.9M | 34.6M | 34.4M | 35.9M | 38.0M | 39.9M | |
| Other Non Cash Items | 8.7M | 31.7M | 7.2M | 5.1M | 5.7M | 5.5M | |
| Capital Expenditures | 4.7M | 6.9M | 47.8M | 30.3M | 20.2M | 12.5M | |
| Net Income | 15.4M | (120.3M) | (49.6M) | (99.2M) | (134.7M) | (127.9M) | |
| End Period Cash Flow | 71.8M | 106.2M | 110.1M | 126.6M | 99.3M | 56.5M | |
| Investments | 106K | (196.3M) | (8.4M) | 75.9M | 43.7M | 45.9M | |
| Change To Netincome | 37.0M | 45.6M | 34.9M | 40.8M | 46.9M | 26.9M | |
| Change Receivables | (6.6M) | 2.2M | 1.7M | (3.1M) | (3.6M) | (3.8M) |
Glaukos Corp Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Glaukos Corp or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Glaukos Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Glaukos stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | 1.68 | |
σ | Overall volatility | 2.31 | |
Ir | Information ratio | 0.02 |
Glaukos Corp Volatility Alert
Glaukos Corp has relatively low volatility with skewness of 1.41 and kurtosis of 4.67. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Glaukos Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Glaukos Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Glaukos Corp Fundamentals Vs Peers
Comparing Glaukos Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Glaukos Corp's direct or indirect competition across all of the common fundamentals between Glaukos Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Glaukos Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Glaukos Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Glaukos Corp by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Glaukos Corp to competition |
| Fundamentals | Glaukos Corp | Peer Average |
| Return On Equity | -0.26 | -0.31 |
| Return On Asset | -0.0774 | -0.14 |
| Profit Margin | (0.42) % | (1.27) % |
| Operating Margin | (0.26) % | (5.51) % |
| Current Valuation | 7.83 B | 16.62 B |
| Shares Outstanding | 55.14 M | 571.82 M |
| Shares Owned By Insiders | 3.19 % | 10.09 % |
| Shares Owned By Institutions | 96.81 % | 39.21 % |
| Number Of Shares Shorted | 2.64 M | 4.71 M |
| Price To Earning | 94.70 X | 28.72 X |
| Price To Book | 11.88 X | 9.51 X |
| Price To Sales | 22.03 X | 11.42 X |
| Revenue | 314.71 M | 9.43 B |
| Gross Profit | 213.88 M | 27.38 B |
| EBITDA | (82.12 M) | 3.9 B |
| Net Income | (134.66 M) | 570.98 M |
| Cash And Equivalents | 391.19 M | 2.7 B |
| Cash Per Share | 8.22 X | 5.01 X |
| Total Debt | 383.74 M | 5.32 B |
| Debt To Equity | 0.68 % | 48.70 % |
| Current Ratio | 6.78 X | 2.16 X |
| Book Value Per Share | 12.13 X | 1.93 K |
| Cash Flow From Operations | (57.76 M) | 971.22 M |
| Short Ratio | 6.00 X | 4.00 X |
| Earnings Per Share | (2.92) X | 3.12 X |
| Price To Earnings To Growth | 1.64 X | 4.89 X |
| Target Price | 141.67 | |
| Number Of Employees | 907 | 18.84 K |
| Beta | 1.03 | -0.15 |
| Market Capitalization | 7.94 B | 19.03 B |
| Total Asset | 940.41 M | 29.47 B |
| Retained Earnings | (599.07 M) | 9.33 B |
| Working Capital | 321.45 M | 1.48 B |
Note: Acquisition by Joseph Gilliam of 200 shares of Glaukos Corp at 55.18 subject to Rule 16b-3 [view details]
Glaukos Corp Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Glaukos . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Glaukos Corp Buy or Sell Advice
When is the right time to buy or sell Glaukos Corp? Buying financial instruments such as Glaukos Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Glaukos Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large & Mid Caps ETFs Thematic Idea Now
Large & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.